Gastric Motility Disorder Completed Phase 4 Trials for Methylnaltrexone (DB06800)

IndicationStatusPhase
DBCOND0045978 (Gastric Motility Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01055704Effect of Methylnaltrexone on GI Transit in Healthy VolunteersTreatment